Evidence map›Paper›PMID 24348541›Full record

ArticleGastroenterology research and practice2013

Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated.

Michele Ammendola, Rosario Sacco, Giuseppe Sammarco, Giuseppe Donato, Valeria Zuccalà, Roberto Romano, Maria Luposella, Rosa Patruno, Carlo Vallicelli, Giorgio Maria Verdecchia and 3 more

Open access · goldAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Tryptase and tumor angiogenesis.Frontiers in oncology · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Involvement of Mast Cells in the Pathophysiology of Pain.Frontiers in cellular neuroscience · 2021
    Article
  10. Article
  11. Review
  12. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer.International journal of molecular sciences · 2019
    Review
  13. Mast Cells and Angiogenesis in Human Plasma Cell Malignancies.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Are Mast Cells MASTers in Cancer?Frontiers in immunology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michele AmmendolaDepartment of Medical and Surgery Science, Clinical Surgery Unit, University of Catanzaro "Magna Graecia" Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Rosario SaccoDepartment of Medical and Surgery Science, Clinical Surgery Unit, University of Catanzaro "Magna Graecia" Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Giuseppe SammarcoDepartment of Medical and Surgery Science, Clinical Surgery Unit, University of Catanzaro "Magna Graecia" Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Giuseppe DonatoHealth Science Department, Pathology Unit, University of Catanzaro "Magna Graecia" Medical School, 88100 Catanzaro, Italy.
Valeria ZuccalàHealth Science Department, Pathology Unit, University of Catanzaro "Magna Graecia" Medical School, 88100 Catanzaro, Italy.
Roberto RomanoDepartment of Medical and Surgery Science, Clinical Surgery Unit, University of Catanzaro "Magna Graecia" Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Maria LuposellaDepartment of Medical and Surgery Science, Cardiovascular Disease Unit, University of Catanzaro "Magna Graecia" Medical School, 88100 Catanzaro, Italy.
Rosa PatrunoSurgery Unit, National Cancer Research Centre, Giovanni Paolo II, 70100 Bari, Italy.
Carlo VallicelliDepartment of Surgery, Surgical Oncology Unit, Ospedale Morgagni-Pierantoni, 47121 Forlì, Italy.
Giorgio Maria VerdecchiaDepartment of Surgery, Surgical Oncology Unit, Ospedale Morgagni-Pierantoni, 47121 Forlì, Italy.
Davide CavaliereDepartment of Surgery, Surgical Oncology Unit, Ospedale Morgagni-Pierantoni, 47121 Forlì, Italy.
Severino MontemurroSurgery Unit, National Cancer Research Centre, Giovanni Paolo II, 70100 Bari, Italy.
Girolamo RanieriInterventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, "Giovanni Paolo II", 70100 Bari, Italy.
Magna Graecia University · ITIstituto Tumori Bari · ITOspedale G.B. Morgagni - L.Pierantoni · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Angiogenesis is a complex process involved in both growth and progression of several human and animal tumours. Tryptase is a serin protease stored in mast cells granules, which plays a role in tumour angiogenesis. Mast cells (MCs) can release tryptase following c-Kit receptor (c-KitR) activation. Method. In a series of 25 gastric cancer patients with stage T3N2-3M0 (by AJCC for Gastric Cancer 7th Edition), immunohistochemistry and image analysis methods were employed to evaluate in the tumour tissue the correlation between the number of mast cells positive to tryptase (MCPT), c-KitR expressing cells (c-KitR-EC), and microvascular density (MVD). Results. Data demonstrated a positive correlation between MCPT, c-KitR-EC, and MVD to each other. In tumour tissue the mean number of MCPT was 15, the mean number of c-KitR-EC was 20, and the mean number of MVD was 20. The Pearson test correlating MCPT and MVD, c-KitR-EC and MVD was significantly (r = 0.64, P = 0.001; r = 0.66, P = 0.041, resp.). Conclusion. In this pilot study, we suggest that MCPT and c-KitR-EC play a role in gastric cancer angiogenesis, so we think that several c-KitR or tryptase inhibitors such as gabexate mesilate and nafamostat mesilate might be evaluated in clinical trials as a new antiangiogenetic approach.

Identifiers

PMID24348541
PMCPMC3853922
OpenAlexW2075816567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.